The United States Pharmacopeial Convention (USP), a scientific nonprofit organization that sets standards for the identity, strength, quality, and purity of medicines, food ingredients, and dietary supplements, in association with Indian Pharmacopeia Commission (IPC) is organizing the 12th Science and Standards Symposium in New Delhi. The meeting is being held in collaboration with key stakeholders Association of Biotechnology Led Enterprises (ABLE), Bulk Drug Manufacturers Association (BDMA), Indian drug Manufacturing Association (IDMA), Indian Pharmaceutical Association (IPA), and Organization of Pharmaceutical Producers of India (OPPI) on the April, 16 to April 17, 2013 at New Delhi.

The symposium will include a science-based dialogue among various regulatory stakeholders to address key issues. The key topics include sessions on chemical medicines and excipient and biological medicines besides covering the latest pharmacopeial topics like evaluation of validation practices-ICH Q2 and assessing validation parameters and more, consideration of novel formulations-Solid oral formulations, tropical delivery, injectables and performance tests and more, biotherapeutics: biosimilarity and interchangeability, bioassays, regulatory requirements and more and vaccines- alternatives to animal testing, vaccines adjuvants, thermostable vaccines and more.

Besides the senior regulators from India and abroad, the officials from World Health Organization (WHO) are also expected to join the deliberations. Among the expected participants are lab managers, lab technicians, research associates, project leaders, lab analyst, personnel working in biosimilars, vaccines, bio therapeutic industries, manufacturers, exporters and importers of medicines and their ingredients, policy makers, academicians, and others interested in compendial matters.